Skip to main content

Advertisement

Table 4 Prevalence of MetS and concordance evaluation between FPG and HbA1c in diagnosing MetS

From: Prevalence of metabolic syndrome and the comparison of fasting plasma glucose and HbA1c as the glycemic criterion for MetS definition in non-diabetic population in Ghana

MetS criteria Overall Female Male
IDF
 Model 1 123 (46.6) 92 (58.6) 31 (29.0)
 Model 2 143 (54.2) 107 (68.2) 36 (33.6)
 Overlap 117 (44.3) 87 (55.4) 30 (28.0)
 Kappa 0.759 0.660 0.848
NCEP ATP III
 Model 1 98 (37.1) 74 (47.1) 24 (22.4)
 Model 2 139 (52.7) 100 (63.7) 39 (36.4)
 Overlap 98 (37.1) 74 (47.1) 24 (22.4)
 Kappa 0.694 0.674 0.670
WHO
 Model 1 33 (12.5) 24 (15.3) 9 (8.4)
 Model 2 112 (42.4) 63 (40.1) 49 (45.8)
 Overlap 20 (7.6) 14 (8.9) 6 (5.6)
 Kappa 0.103 0.129 0.075
  1. Model 1; traditional FPG criteria. Model 2; traditional criteria with the glycemic component replaced by HbA1c. The kappa (ĸ) statistic was used to evaluate the agreement between FPG-(model 1) and HbA1c-based identification of MetS (model 2), Overlap; Diagnosing of same patient with MetS by both FPG and HbA1c